Related Experiment Video
Updated: Jul 8, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic
Thai M Cao1, David Durrant, Ashutosh Tripathi
1Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Abstract:
Stilbenes are a group of natural compounds with many biological activities. Two highly potent stilbenes, cis-3,4',5-trimethoxy-3'-aminostilbene (stilbene 5c) and cis-3,4',5-trimethoxy-3'-hydroxystilbene (stilbene 6c) induce G2/M cell-cycle arrest and leukemic cell death in nanomolarity range without affecting normal bone marrow progenitor cells. The mechanism of stilbenes is mediated by interfering with microtubule polymerization through the colchicine-binding site. Docking of the stilbenes into tubulin structure confirms that stilbenes fit into the colchicine-binding pocket. Animal studies show that stilbenes are well tolerated in mice and are capable of inducing more than 50% leukemic cell death by a single dose injection. A 5-day treatment with low-dose stilbenes suppresses tumor growth in mice with established tumor xenografts. No major organ damage was detected by histological section. Our results indicate that stilbene 5c is a microtubule-interfering agent and can be potentially useful in leukemic therapy.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
Inhibitors of Bacterial DNA Synthesis
Antiprotozoal Agents
Anthelminthic Agents

